Source:http://linkedlifedata.com/resource/pubmed/id/10655153
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2000-2-29
|
pubmed:abstractText |
Deficiency of glycogen debranching enzyme (AGL) activity causes glycogen storage disease type III (GSD-III). Generalized loss of AGL activity results in GSD-IIIa, and muscle-specific retention of AGL activity results in GSD-IIIb. To date, no common mutation has been described among GSD-III patients, except for three alleles; two linked specifically with GSD-IIIb, and the third found only in North African Jews with GSD-IIIa. Here we report two frequent mutations, each of which was found in the homozygous state in multiple patients, and each of which was associated with a subset of clinical phenotype in those patients with that mutation. A novel point mutation of a single T deletion at cDNA position 3964 (3964delT) was first detected in an African American patient, who has a severe phenotype and early onset of clinical symptoms. The second mutation was an A to G transition at position -12 upstream of the 3' splice site of intron 32 (IVS32-12A > G). This lesion, previously implicated as a IIIb mutation in a Japanese patient, was identified in a confirmed GSD-IIIa Caucasian patient presenting with mild clinical symptoms. These two mutations together account for more than 12% of the molecular defects in the GSD-III patients tested. Our molecular and clinical data suggest a genotype-phenotype correlation for each of these mutations. Furthermore, this current study, coupled with our previous reports, describes the molecular tools necessary for the development of a DNA-based diagnostic test for GSD-III.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1096-7192
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2000 Academic Press.
|
pubmed:issnType |
Print
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
16-23
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10655153-Adult,
pubmed-meshheading:10655153-African Continental Ancestry Group,
pubmed-meshheading:10655153-Age of Onset,
pubmed-meshheading:10655153-Base Sequence,
pubmed-meshheading:10655153-European Continental Ancestry Group,
pubmed-meshheading:10655153-Exons,
pubmed-meshheading:10655153-Female,
pubmed-meshheading:10655153-Genotype,
pubmed-meshheading:10655153-Glycogen Debranching Enzyme System,
pubmed-meshheading:10655153-Glycogen Storage Disease Type III,
pubmed-meshheading:10655153-Humans,
pubmed-meshheading:10655153-Introns,
pubmed-meshheading:10655153-Male,
pubmed-meshheading:10655153-Phenotype,
pubmed-meshheading:10655153-Point Mutation,
pubmed-meshheading:10655153-Polymorphism, Single-Stranded Conformational,
pubmed-meshheading:10655153-RNA Splicing
|
pubmed:year |
2000
|
pubmed:articleTitle |
Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease.
|
pubmed:affiliation |
Division of Medical Genetics, Duke University Medical Center, Durham, North Carolina, 27710, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|